Last week I told you three deals entered the board, one was contraindicated, and two were still worth the workup. This week the board changed again.

The flooring operation — the one with the best margins, the semi-absentee model, the deal I'd called the lead — went quiet. Not in a dramatic way. In the worst way. I'd done the analysis, and on paper the numbers looked solid. Then I asked the broker for updated financials. He'd been asking the seller too. The current-year numbers didn't come. What came instead was a signal: revenue may be down significantly, and the owner isn't particularly engaged in getting the picture clear.

I'm putting it on hold. The broker knows where I stand — if updated financials materialize, he'll pass them along. But I'm not pricing a story when the numbers behind it won't show up.

That leaves the med spa. Not as a backup. As the only deal still standing.

———

Every ER doc knows the phrase. You write it in the chart when the history keeps shifting: patient is a poor historian. The timeline doesn't track. The details change between tellings. The key questions get vague answers or no answers at all.

You don't write it to be unkind. You write it because it changes how you run the workup. When the history is unreliable, you can't anchor your diagnosis to the story. You have to lean harder on the objective data — the labs, the imaging, the vitals that don't depend on what the patient tells you. The absence of a clear history doesn't mean there's no diagnosis. It means the path to it runs through something more concrete.

That's what happened with the flooring deal. The listing-level numbers told a good story. The analysis tracked. But when I needed the current chapter — the year-to-date financials that would tell me what the business is doing right now, not what it did last year — the story stopped. A seller who can't or won't produce current financials has, in a way, already told you something. The absence of data is data.

And here's what I want to be honest about: it would have been easy to keep chasing. The deal looked right. The model fit. Walking away from a deal that's contraindicated — like the painting and drywall company last week — is clean. Putting a deal on hold when it looked like the best one on the board is harder. It requires trusting the process more than the attachment.

But the lesson from the poor historian isn't just about what you walk away from. It's about what you walk toward. The med spa has done the opposite at every turn — answers came back the same day I sent questions, the broker has been responsive and organized, and the conversation has moved forward in a straight line. When one deal goes quiet and another one keeps showing up with clean answers, you don't have to overthink which one gets your time.

———

Three deals entered the pipeline over the past few weeks. One was contraindicated. One became a poor historian. One kept answering.

The med spa is now the sole active deal, and it's advancing. I have a meeting with the broker and the seller tomorrow. I've prepped for it — structured questions, clear priorities, a plan for what I need to learn from the conversation. This isn't my first time sitting across from a seller, but it's the first time I'm walking into that room with only one deal on the board. That focus changes the energy.

Lacy is supportive as always. The clinical background gives us an edge most buyers don't carry into a med spa — I understand the operations, the compliance landscape, the staffing model. That doesn't make it the right deal. But it means the questions I'm asking are the right questions, and that's how you earn a seller's trust before you ever talk about price.

———

The meeting. Tomorrow. My goals are specific: understand how the business actually runs day to day, and understand why they're selling. Everything else — price, terms, structure — comes later. The first conversation with a seller isn't a negotiation. It's a clinical interview. You're not there to close. You're there to listen.

And on the flooring deal, the boundary is set. Updated financials or we're done. I decided that before any pressure, before any follow-up call — because the only way to keep a decision clean is to make it before you're in the room.

Nineteen weeks. Three deals evaluated. Two cleared from the board. One advancing. The system is working exactly the way it's supposed to — not by finding the perfect deal on the first pass, but by eliminating the ones that aren't right until you're standing in front of one that might be.

———

— Joe & Lacy

When the story stops adding up, trust the labs.

Subscribe to Acquisition Rx | Follow on X | LinkedIn